Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

November 15, 1988; Volume 141,Issue 10

ARTICLES

  • You have accessRestricted access
    Target cell lysis by cytotoxic T lymphocytes that lack detectable hemolytic perforin activity.
    N L Allbritton, C Nagler-Anderson, T J Elliott, C R Verret and H N Eisen
    J Immunol November 15, 1988, 141 (10) 3243-3248;
  • You have accessRestricted access
    Differential activation requirements for virgin and memory T cells.
    J A Byrne, J L Butler and M D Cooper
    J Immunol November 15, 1988, 141 (10) 3249-3257;
  • You have accessRestricted access
    Activation events in hapten-specific B cells from tolerant mice.
    J H Chace and D W Scott
    J Immunol November 15, 1988, 141 (10) 3258-3262;
  • You have accessRestricted access
    Activation of human T lymphocytes by bryostatin.
    A D Hess, M K Silanskis, A H Esa, G R Pettit and W S May
    J Immunol November 15, 1988, 141 (10) 3263-3269;
  • You have accessRestricted access
    Construction of antigen-specific suppressor T cell hybridomas from spleen cells of mice primed for the persistent IgE antibody formation.
    M Iwata and K Ishizaka
    J Immunol November 15, 1988, 141 (10) 3270-3277;
  • You have accessRestricted access
    Molecular analysis of the dissociation between IL-2 production and proliferation in a response of a T cell clone to the antigen presented by B cells.
    T Kakiuchi, J Mizuguchi and H Nariuchi
    J Immunol November 15, 1988, 141 (10) 3278-3284;
  • You have accessRestricted access
    Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
    K Kosmatopoulos, D Scott-Algara and O Halle-Pannenko
    J Immunol November 15, 1988, 141 (10) 3285-3292;
  • You have accessRestricted access
    Antigen processing and the human T cell receptor repertoire for insulin.
    G G Miller, J F Hoy, L J Nell and J W Thomas
    J Immunol November 15, 1988, 141 (10) 3293-3298;
  • You have accessRestricted access
    Resistance of primary CD8+ cytotoxic T lymphocytes to lysis by cytotoxic granules from cloned T cell lines.
    C Nagler-Anderson, C R Verret, A A Firmenich, M Berne and H N Eisen
    J Immunol November 15, 1988, 141 (10) 3299-3305;
  • You have accessRestricted access
    Bone marrow cells from allogeneic bone marrow chimeras inhibit the generation of cytotoxic lymphocyte responses against both donor and recipient cells.
    M Ogasawara, K Iwabuchi, R A Good and K Onoe
    J Immunol November 15, 1988, 141 (10) 3306-3312;
  • You have accessRestricted access
    Selective inhibition of antigen presentation to cloned T cells by protease inhibitors.
    J Puri and Y Factorovich
    J Immunol November 15, 1988, 141 (10) 3313-3317;
  • You have accessRestricted access
    The expression and functional involvement of laminin-like molecules in non-MHC restricted cytotoxicity by human Leu-19+/CD3- natural killer lymphocytes.
    R E Schwarz and J C Hiserodt
    J Immunol November 15, 1988, 141 (10) 3318-3323;
  • You have accessRestricted access
    Class I MHC-restricted recognition of cells expressing a gene encoding a 41 amino acid product of the influenza hemagglutinin.
    M T Sweetser, V L Braciale and T J Braciale
    J Immunol November 15, 1988, 141 (10) 3324-3328;
  • You have accessRestricted access
    Subtypes of helper cells. Non-inflammatory type 1 helper T cells.
    R L Wong, N H Ruddle, S J Padula, E G Lingenheld, C M Bergman, R V Rugen, D I Epstein and R B Clark
    J Immunol November 15, 1988, 141 (10) 3329-3334;
  • You have accessRestricted access
    B cells expressing Ig transgenes respond to a T-dependent antigen only in the presence of Ia-compatible T cells.
    R L O'Brien, P Marrack, U Storb and J W Kappler
    J Immunol November 15, 1988, 141 (10) 3335-3341;
  • You have accessRestricted access
    Soluble factors in tolerance and contact sensitivity to 2,4-dinitro-fluorobenzene in mice. IX. A monoclonal T cell suppressor molecule is structurally and serologically related to the alpha/beta T cell receptor.
    R L Fairchild, R T Kubo and J W Moorhead
    J Immunol November 15, 1988, 141 (10) 3342-3348;
  • You have accessRestricted access
    In vivo and in vitro production of IFN-beta and IFN-gamma during graft vs host disease.
    M G Cleveland, C R Annable and G R Klimpel
    J Immunol November 15, 1988, 141 (10) 3349-3356;
  • You have accessRestricted access
    Characterization of human peripheral lymphocytes expressing the CD3-gamma/delta complex with anti-receptor monoclonal antibodies.
    F Faure, S Jitsukawa, F Triebel and T Hercend
    J Immunol November 15, 1988, 141 (10) 3357-3360;
  • You have accessRestricted access
    Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis.
    Y Fujii and J Lindstrom
    J Immunol November 15, 1988, 141 (10) 3361-3369;
  • You have accessRestricted access
    Allogeneic MHC antigen requirements for lupus-like autoantibody production and nephritis in murine graft-vs-host disease.
    J P Portanova, F M Ebling, W S Hammond, B H Hahn and B L Kotzin
    J Immunol November 15, 1988, 141 (10) 3370-3376;
  • You have accessRestricted access
    Lethal graft-vs-host disease induced by a class II MHC antigen only disparity is not mediated by cytotoxic T cells.
    D L Thiele, S E Bryde and P E Lipsky
    J Immunol November 15, 1988, 141 (10) 3377-3382;
  • You have accessRestricted access
    Effects of granulocyte-macrophage colony-stimulating factor and colony-stimulating factor-1 on the proliferation and differentiation of murine alveolar macrophages.
    K S Akagawa, K Kamoshita and T Tokunaga
    J Immunol November 15, 1988, 141 (10) 3383-3390;
  • You have accessRestricted access
    IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor.
    F Breviario, F Bertocchi, E Dejana and F Bussolino
    J Immunol November 15, 1988, 141 (10) 3391-3397;
  • You have accessRestricted access
    Pre-exposure of human B cells to recombinant IL-1 enhances subsequent proliferation.
    A S Freedman, G Freeman, J Whitman, J Segil, J Daley and L M Nadler
    J Immunol November 15, 1988, 141 (10) 3398-3404;
  • You have accessRestricted access
    The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo.
    D A Hume, P Pavli, R E Donahue and I J Fidler
    J Immunol November 15, 1988, 141 (10) 3405-3409;
  • You have accessRestricted access
    Tumor necrosis factor-alpha and tumor necrosis factor-beta (lymphotoxin) stimulate the production of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and IL-1 in vivo.
    K Kaushansky, V C Broudy, J M Harlan and J W Adamson
    J Immunol November 15, 1988, 141 (10) 3410-3415;
  • You have accessRestricted access
    IL-4 induces loss of B lymphocyte Fc gamma R II ligand binding capacity.
    G Laszlo and H B Dickler
    J Immunol November 15, 1988, 141 (10) 3416-3421;
  • You have accessRestricted access
    Limiting dilution analysis of TNF producing cells in C3H/HeJ mice.
    E C Lattime, A Stoppacciaro and O Stutman
    J Immunol November 15, 1988, 141 (10) 3422-3428;
  • You have accessRestricted access
    Cholera toxin discriminates between murine T lymphocyte proliferation stimulated by activators of protein kinase C and proliferation stimulated by IL-2. Possible role for intracellular cAMP.
    D K Kim, G J Nau, D W Lancki, G Dawson and F W Fitch
    J Immunol November 15, 1988, 141 (10) 3429-3437;
  • You have accessRestricted access
    Expression of CD5 regulates responsiveness to IL-1.
    Y Nishimura, B E Bierer and S J Burakoff
    J Immunol November 15, 1988, 141 (10) 3438-3444;
  • You have accessRestricted access
    Characterization of T helper 1 and 2 cell subsets in normal mice. Helper T cells responsible for IL-4 and IL-5 production are present as precursors that require priming before they develop into lymphokine-secreting cells.
    S L Swain, D T McKenzie, A D Weinberg and W Hancock
    J Immunol November 15, 1988, 141 (10) 3445-3455;
  • You have accessRestricted access
    Lymphokine-independent induction of macrophage membrane IL-1 by autoreactive T cells recognizing either class I or class II MHC determinants.
    M A Wasik, R P Donnelly and D I Beller
    J Immunol November 15, 1988, 141 (10) 3456-3462;
  • You have accessRestricted access
    Characterization of protein kinase C and its isoforms in human T lymphocytes.
    A D Beyers, C Hanekom, A Rheeder, A F Strachan, M W Wooten and A E Nel
    J Immunol November 15, 1988, 141 (10) 3463-3470;
  • You have accessRestricted access
    Characterization of granzymes A and B isolated from granules of cloned human cytotoxic T lymphocytes.
    O Krähenbühl, C Rey, D Jenne, A Lanzavecchia, P Groscurth, S Carrel and J Tschopp
    J Immunol November 15, 1988, 141 (10) 3471-3477;
  • You have accessRestricted access
    Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes.
    L L Lanier, J J Ruitenberg and J H Phillips
    J Immunol November 15, 1988, 141 (10) 3478-3485;
  • You have accessRestricted access
    Study of the epitope structure of purified Dac G I and Lol p I, the major allergens of Dactylis glomerata and Lolium perenne pollens, using monoclonal antibodies.
    W Mourad, S Mécheri, G Peltre, B David and J Hébert
    J Immunol November 15, 1988, 141 (10) 3486-3491;
  • You have accessRestricted access
    An 80 to 85 kilodalton human phosphoglycoprotein associated with cell activation.
    M B Omary, D Kelleher and M F Kagnoff
    J Immunol November 15, 1988, 141 (10) 3492-3497;
  • You have accessRestricted access
    Is a natural ligand of the T lymphocyte CD2 molecule a sulfated carbohydrate?
    C R Parish, V McPhun and H S Warren
    J Immunol November 15, 1988, 141 (10) 3498-3504;
  • You have accessRestricted access
    Identification and partial characterization of human platelet C1q binding sites.
    E I Peerschke and B Ghebrehiwet
    J Immunol November 15, 1988, 141 (10) 3505-3511;
  • You have accessRestricted access
    Possible association between IL-2 receptors and class I HLA molecules on T cells.
    M Sharon, J R Gnarra, M Baniyash and W J Leonard
    J Immunol November 15, 1988, 141 (10) 3512-3515;
  • You have accessRestricted access
    Human monoclonal anti-idiotypic antibodies. I. Establishment of immortalized cell lines from a tumor patient treated with mouse monoclonal antibodies.
    M Steinitz, S Tamir, J E Frödin, A K Lefvert and H Mellstedt
    J Immunol November 15, 1988, 141 (10) 3516-3522;
  • You have accessRestricted access
    The physical-chemical characterization and biologic activity of serum released lipopolysaccharides.
    V L Tesh and D C Morrison
    J Immunol November 15, 1988, 141 (10) 3523-3531;
  • You have accessRestricted access
    Tyrosine phosphorylation of the human T cell antigen receptor zeta-chain: activation via CD3 but not CD2.
    A M Weissman, P Ross, E T Luong, P Garcia-Morales, M L Jelachich, W E Biddison, R D Klausner and L E Samelson
    J Immunol November 15, 1988, 141 (10) 3532-3536;
  • You have accessRestricted access
    Phagocytosis of serum-opsonized zymosan down-regulates the expression of CR3 and FcRI in the membrane of human monocytes.
    H M Wolf, J W Mannhalter, H C Salzmann, J Göttlicher, R Ahmad and M M Eibl
    J Immunol November 15, 1988, 141 (10) 3537-3543;
  • You have accessRestricted access
    The in vivo production of peptide leukotrienes after pulmonary anaphylaxis in the rat.
    A Foster, G Letts, S Charleson, B Fitzsimmons, B Blacklock and J Rokach
    J Immunol November 15, 1988, 141 (10) 3544-3550;
  • You have accessRestricted access
    Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
    H R Hill, J F Bohnsack, E Z Morris, N H Augustine, C J Parker, P P Cleary and J T Wu
    J Immunol November 15, 1988, 141 (10) 3551-3556;
  • You have accessRestricted access
    Agents that mimic antigen receptor signaling inhibit proliferation of cloned murine T lymphocytes induced by IL-2.
    G J Nau, D K Kim and F W Fitch
    J Immunol November 15, 1988, 141 (10) 3557-3563;
  • You have accessRestricted access
    Substance P, neurokinin A, and neurokinin B induce generation of IL-1-like activity in P388D1 cells. Possible relevance to arthritic disease.
    E S Kimball, F J Persico and J L Vaught
    J Immunol November 15, 1988, 141 (10) 3564-3569;
  • You have accessRestricted access
    Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
    R M Senior, G L Griffin, H D Perez and R O Webster
    J Immunol November 15, 1988, 141 (10) 3570-3574;
  • You have accessRestricted access
    Neutrophils and mast cells. Comparison of neutrophil-derived histamine-releasing activity with other histamine-releasing factors.
    M V White, A P Kaplan, M Haak-Frendscho and M Kaliner
    J Immunol November 15, 1988, 141 (10) 3575-3583;
  • You have accessRestricted access
    Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii.
    J L Burg, D Perelman, L H Kasper, P L Ware and J C Boothroyd
    J Immunol November 15, 1988, 141 (10) 3584-3591;
  • You have accessRestricted access
    Mapping the immunodeterminants of the complete streptococcal M6 protein molecule. Identification of an immunodominant region.
    V A Fischetti and M Windels
    J Immunol November 15, 1988, 141 (10) 3592-3599;
  • You have accessRestricted access
    Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii.
    I A Khan, K A Smith and L H Kasper
    J Immunol November 15, 1988, 141 (10) 3600-3605;
  • You have accessRestricted access
    Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies.
    J Kimura-Kuroda and K Yasui
    J Immunol November 15, 1988, 141 (10) 3606-3610;
  • You have accessRestricted access
    Abnormal regulation of IFN-alpha, -beta, and -gamma expression in MAIDS, a murine retrovirus-induced immunodeficiency syndrome.
    P M Pitha, D Biegel, R A Yetter and H C Morse 3rd
    J Immunol November 15, 1988, 141 (10) 3611-3616;
  • You have accessRestricted access
    Comparative immunogenicity of hepatitis B virus core and E antigens.
    D R Milich, A McLachlan, S Stahl, P Wingfield, G B Thornton, J L Hughes and J E Jones
    J Immunol November 15, 1988, 141 (10) 3617-3624;
  • You have accessRestricted access
    Lineage and stage specificity of isotype switching in humans.
    G V Borzillo, M D Cooper, L F Bertoli, A Landay, R Castleberry and P D Burrows
    J Immunol November 15, 1988, 141 (10) 3625-3633;
  • You have accessRestricted access
    Patterns of Ig V region expression among neonatal hemagglutinin-responsive B cells. Evidence for non-random VH gene representation during later stages of development.
    L J Kienker, J M Korostoff and M P Cancro
    J Immunol November 15, 1988, 141 (10) 3634-3641;
  • You have accessRestricted access
    Isolation and analysis of murine serum amyloid P component cDNA clones.
    J E Mole, B L Beaulieu, C A Geheran, J A Carnazza and J K Anderson
    J Immunol November 15, 1988, 141 (10) 3642-3646;
  • You have accessRestricted access
    Defective E beta expression in three mouse H-2 haplotypes results from aberrant RNA splicing.
    F M Tacchini-Cottier and P P Jones
    J Immunol November 15, 1988, 141 (10) 3647-3653;
  • You have accessRestricted access
    Molecular basis for the defective expression of the mouse Ew17 beta gene.
    T H Vu, F M Tacchini-Cottier, C E Day, A B Begovich and P P Jones
    J Immunol November 15, 1988, 141 (10) 3654-3661;
  • You have accessRestricted access
    Bispecific F(ab' gamma)2 antibody for the delivery of saporin in the treatment of lymphoma.
    M J Glennie, D M Brennand, F Bryden, H M McBride, F Stirpe, A T Worth and G T Stevenson
    J Immunol November 15, 1988, 141 (10) 3662-3670;
  • You have accessRestricted access
    Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2.
    R L Hornung, T C Back, D S Zaharko, W J Urba, D L Longo and R H Wiltrout
    J Immunol November 15, 1988, 141 (10) 3671-3679;
  • You have accessRestricted access
    Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
    A Sampson-Johannes and J A Carlino
    J Immunol November 15, 1988, 141 (10) 3680-3686;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 141, Issue 10
15 Nov 1988
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • ARTICLES
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606